These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31880847)

  • 1. Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease-specific assessments.
    Salek S; Boscoe AN; Piantedosi S; Egan S; Evans CJ; Wells T; Cohen J; Klaassen RJ; Grace R; Storm M
    Eur J Haematol; 2020 May; 104(5):427-434. PubMed ID: 31880847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.
    Andrae DA; Grace RF; Jewett A; Foster B; Klaassen RJ; Salek S; Li J; Tai F; Boscoe AN; Zagadailov E
    J Patient Rep Outcomes; 2023 Nov; 7(1):112. PubMed ID: 37943362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of disease in pyruvate kinase deficiency: Patients' perception of the impact on health-related quality of life.
    Grace RF; Cohen J; Egan S; Wells T; Witherspoon B; Ryan A; Salek SS; Bodie S; Klaassen RJ
    Eur J Haematol; 2018 Dec; 101(6):758-765. PubMed ID: 29935049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency.
    Salek MS; Ionova T; Johns JR; Oliva EN
    Qual Life Res; 2019 Feb; 28(2):399-410. PubMed ID: 30456713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities and complications in adults with pyruvate kinase deficiency.
    Boscoe AN; Yan Y; Hedgeman E; van Beers EJ; Al-Samkari H; Barcellini W; Eber SW; Glader B; Yaish HM; Chonat S; Sharma M; Kuo KHM; Neufeld EJ; Wang H; Verhovsek M; Sheth S; Grace RF
    Eur J Haematol; 2021 Apr; 106(4):484-492. PubMed ID: 33370479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of pyruvate kinase deficiency: A systematic literature review.
    Secrest MH; Storm M; Carrington C; Casso D; Gilroy K; Pladson L; Boscoe AN
    Eur J Haematol; 2020 Aug; 105(2):173-184. PubMed ID: 32279356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency.
    van Straaten S; Bierings M; Bianchi P; Akiyoshi K; Kanno H; Serra IB; Chen J; Huang X; van Beers E; Ekwattanakit S; Güngör T; Kors WA; Smiers F; Raymakers R; Yanez L; Sevilla J; van Solinge W; Segovia JC; van Wijk R
    Haematologica; 2018 Feb; 103(2):e82-e86. PubMed ID: 29242305
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency.
    Kuo KHM; Grace RF; van Beers EJ; Barcellini W; Glenthøj A; Holzhauer S; Beynon V; Morris S; Li J; Zagadailov E; Patel P; Al-Samkari H
    Am J Hematol; 2024 Jul; 99(7):1415-1419. PubMed ID: 38712615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
    Grace RF; Bianchi P; van Beers EJ; Eber SW; Glader B; Yaish HM; Despotovic JM; Rothman JA; Sharma M; McNaull MM; Fermo E; Lezon-Geyda K; Morton DH; Neufeld EJ; Chonat S; Kollmar N; Knoll CM; Kuo K; Kwiatkowski JL; Pospíšilová D; Pastore YD; Thompson AA; Newburger PE; Ravindranath Y; Wang WC; Wlodarski MW; Wang H; Holzhauer S; Breakey VR; Kunz J; Sheth S; Rose MJ; Bradeen HA; Neu N; Guo D; Al-Sayegh H; London WB; Gallagher PG; Zanella A; Barcellini W
    Blood; 2018 May; 131(20):2183-2192. PubMed ID: 29549173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanaka KR, Valentine WN, Miwa S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood. 1962;19(3):267-295.
    Blood; 2016 May; 127(21):2505. PubMed ID: 27231390
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency in a Costa Rican family carrying hemoglobin C disease].
    Chaves M; Vives-Corrons JL; Sáenz GF; Pujades MA; Briceño J; Colomer D
    Sangre (Barc); 1990 Apr; 35(2):128-33. PubMed ID: 2363093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord blood transplantation in a young child with pyruvate kinase deficiency.
    Akiyoshi K; Sekiguchi K; Okamoto T; Suenobu S; Izumi T
    Pediatr Int; 2016 Jul; 58(7):634-6. PubMed ID: 27460399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyserythropoiesis in a child with pyruvate kinase deficiency and coexistent unilateral multicystic dysplastic kidney.
    Haija MA; Qian YW; Muthukumar A
    Pediatr Blood Cancer; 2014 Aug; 61(8):1463-5. PubMed ID: 24481986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency.
    Kung C; Hixon J; Kosinski PA; Cianchetta G; Histen G; Chen Y; Hill C; Gross S; Si Y; Johnson K; DeLaBarre B; Luo Z; Gu Z; Yao G; Tang H; Fang C; Xu Y; Lv X; Biller S; Su SM; Yang H; Popovici-Muller J; Salituro F; Silverman L; Dang L
    Blood; 2017 Sep; 130(11):1347-1356. PubMed ID: 28760888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
    Parekh DS; Eaton WA; Thein SL
    Blood; 2024 Mar; 143(10):866-871. PubMed ID: 38118071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates and advances in pyruvate kinase deficiency.
    Luke N; Hillier K; Al-Samkari H; Grace RF
    Trends Mol Med; 2023 May; 29(5):406-418. PubMed ID: 36935283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Liver Transplantation for Adolescent Patient With Pyruvate Kinase Deficiency-induced Cirrhosis.
    Rinehardt HN; Villella AD; Milanes-Yearsley M; Kelly S; El-Hinnawi A
    J Pediatr Hematol Oncol; 2021 May; 43(4):e605-e607. PubMed ID: 32590423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, monitoring, and management of pyruvate kinase deficiency in children.
    Johnson S; Grace RF; Despotovic JM
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29696. PubMed ID: 35452178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia.
    Klei TRL; Kheradmand Kia S; Veldthuis M; Beuger BM; Geissler J; Dehbozorgian J; Karimi M; van Bruggen R; van Zwieten R
    Eur J Haematol; 2017 Jun; 98(6):584-589. PubMed ID: 28295642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene.
    Jaouani M; Manco L; Kalai M; Chaouch L; Douzi K; Silva A; Macedo S; Darragi I; Boudriga I; Chaouachi D; Fitouri Z; Van Wijk R; Ribeiro ML; Abbes S
    Int J Lab Hematol; 2017 Apr; 39(2):223-231. PubMed ID: 28133914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.